Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients

Journal of Nephrology

Volumn 12, Issue SUPPL. 2, 1999, Pages

  Schena, Francesco Paolo ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b Nephrology Unit Polidinico Piazza Giulio Cesare ^*  (Italy)

Author keywords

Focal segmentai glomerulosclerosis; Membranoproliferative glomerulonephritis; Membranous glomerulonephritis; Minimal change disease; Nephrotic syndrome; Therapy

Indexed keywords

ADULT; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HUMAN; LIPOID NEPHROSIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; REVIEW;

ADULT; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME;

EID: 0000720812     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Chasis H, Goldring W, Baldwin DS. Effect of febrile plasma, typhoid vaccine and nitrogen mustard on renal manifestations of human glomcrulonephritis. Proc Soc Exper Biol Med 1949; 71: 565-7.
2. Arneil GC. Prednisolone treatment of nephrosis. Lancet 1956; 1: 409.
3. Leading article. Immunosuppressive therapy in persistent glomcrulonephritis. Br MedJ 1996; 2: 842-3.
4. Lagrue G, BarietyJ, Halpern B, Miliez P. Les inimuno-dépresseurs en néphrologie essais de traitement des glomérulopathies chroniques primitives. Presse Méd 1967; 75: 1779-81.
5. Goldbeck JH. Experience with alkylating agents in the treatment of children with the nephrotic syndrome. Med J Aust 1963; 2: 987-9.
6. Drummond KN, Michael AF, Good RA, Vernier RL. The nephrotic syndrome of childhood: immunologic, clinical and pathologie correlations. J Clin Invest 1966; 45: 620-30.
7. Shear MA. Mercaptopurine in the treatment of steroid resistant nephrotic syndrome. N Engl J Med 1965; 273: 943-7.
8. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporine A. Br MedJ 1986; 292: 789-92.
9. McCanleyJ, Shapiro R, Ellis D, Igdal H, Tzakis A, Starzl TE. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993; 8: 1286-90.
10. Briggs WA, Choi MJ, Scheel PJ Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998; 31: 213-7.
11. CameronJS. How can we treat glomerulonephritis? Nephrol Dial Transplant 1990; 5 (suppl 1): S16-22.
12. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1988; i: 380-3.
13. International Study of Kidney Disease in Children. The pri-mary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone.J Pediatr 1981; 98: 561-4.
14. Nolasco F, CameronJS, Heywood EF, HicksJ, Ogg C, Williams DG. Adult-onset minimal-change nephrotic syndrome. A long-term follow-up. Kidney Int 1986; 29: 1215-23.
15. Cade R, Mars D, Privette M, Thompson R, Croker B, Peterson J, Campbell K. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Arch Intern Med 1986; 146: 737-41.
16. Ponticelli C, Passerini P. Treatment of the nephrotic syndrome associated with primary glomernlonephritis. Kidney Int 1994; 46: 595-601.
17. BrodehlJ. Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 1991; 35 (suppl 1): S8-15.
18. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Cyclophosphamide treatment of steroid dependant nephrotic syndrome: comparison of eight with 12 week course. Arch Dis Child 1987; 62: 1102-6.
19. Meyrier A, Condamin MC, Broneer D and the Collaborative Group of the French Society of Nephrology. Treatment of adult idiopathic nephrotic syndrome with cyclosporine A. Minimal change disease and focal segmental glomerulosclerosis. Clin Nephrol 1991; 35 (suppl 1): S37-42.
20. Meyrier A, Noel LH, Auriche P, Callard P and the Collaborative Group of the Societede Nephrologie. Long-term renal tolerance of cyclosporine A in adult idiopathic nephrotic syndrome. Kidney Int 1994; 45: 1446-56.
21. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulisclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 1991; 36: 53-9.
22. Korbet SM. The prognosis of focal segmental glomerular sclerosis in adulthood. Medicine 1986; 65: 304-11.
23. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Casa-Alberighi O. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993; 43: 1377-84.
24. F.P. Schena and the Italian Group of Renal Immunopathology. Survey of the Italian registry of renal biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrol Dial Transplant 1997; 12: 418-26.
25. Registre Espanol de Glomerulonefritis. Epidemiologia de las glomerulonefritis en Espana. Resultades de 1993. Nefrologia 1995; 15: 435-44.
26. Davison AM. The United Kingdom Medical Research Council's Glomerulonephritis Regisrty. Contrib Nephrol 1985; 48: 24-35.
27. Erwin DT, DonadioJV, Holley KE. The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc 1973; 48: 697-712.
28. Ehrenreich T, Porush JG, ChurgJ, Garfinkel L, Glabman S, Goldstein MH, Grishman E, Yunis SL. Treatment of idiopathic membranous nephropatliy. N EnglJ Med 1976; 295: 741-6.
29. Piérides AM, Malasit P, Morley AR, Wilkinson R, Uldall PR, Kerr DNS: Idiopathic membranous nephropatliy. Q J Med 1977; 46:163-77.
30. HopperJ, Trew PA, Biava CG. Membranous nephropatliy: its relative benignity in women. Nephron 1981; 29: 18-24.
31. DonadioJV, Holley KE, Anderson CF, Taylor WF. Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 1974; 6: 431-9.
32. Lagrue G, Bernard D, BarietyJ, Druet P, GuenelJ. Traitement par le chlorambucil et l'azathioprine dans les glomérulonéphrites primitives. Résultats d'une étude contrôlée. J Urol Nephrol 1975; 9: 655-72.
33. Silverberg DS, Atkins EL, Ballon HC, et al. Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous gloinerulonephritis. Can Med Assoc J 1976;115:1209-10.
34. Coggins CH, Pinn V, Glassock RR, Border W, et al. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979; 301: 1301-6.
35. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, Sasdelli M, Locatelli F. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1984; 310: 946-50.
36. Ponticelli C. Prognosis and treatment of membranous nephropathy. Kidney Int 1986; 29: 927-40.
37. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, Sasdelli M, Locatelli F. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320: 8-13.
38. Cattran DC, Delmore T, RoscoeJ, Cole E, Cardella C, Charron R, Ritchie S. A randomized controlled trial of prenisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989; 320: 210-5.
39. Cameron JS, Healy MJR, Adu D. The medical research council trial of short-term high dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Quart J Med New Series 1990; 74, 274: 133-56.
40. Murphy'BF, McDonald I, Fairley KF, Kincaid-Smith PS. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. Clin Nephrol 1992; 37: 229-34.
41. Falk RJ, Hogan SL, Muller KE, Jennette C. Treatment of progressive membranous glomerulopathy. A randomized trial / comparing cyclosphamide and corticosteroids with corticosteroids alone. Ann Intern Med 1992; 116: 438-45.
42. Ponticelli C, Zucchelli P, Passerini P, Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N EnglJ Med 1992; 327: 599-603.
43. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizzarri D, Banfi G. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-4.
44. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998; 9: 444-9.
45. Schena FP, Giancaspro V, Strippoli GFM. A review of immunosuppressive therapy in adults with idiopathic nephrotic syndrome. Meta-analysis of randomised controlled trials. (Submitted).
46. Cattran D. Current status of cyclosporin A in the treatment of membranous IgA and membranoproliferative glomerulonephritis. Clin Nepbrol 1991; 1: S43-47.
47. Rostoker G, Belghiti D, Ben Maadi A, Remy P, Lang P, Weil B, Langrue G. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993; 63: 335-41.
48. Short C, Solomon L, Gokal R, Mallick NP. Methylprednisolone in patients with membranous nephropathy and declining renal function. QJ Med 1987; 65:929-34.
49. Mathieson PW, Turner AN, Maidment CG, Evans DJ, Rees AJ. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet 1998; 869-72.
50. Jindal K, West M, Bear R, Bear R, Goldstein M. Long-term benefit of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal funcüon. AmJ Kidney Dis 1992; 19: 61-7.
51. Me Enery PT, McAdams AJ, West CD. The effect of prednisone in a high dose alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine 1986; 64:401-24.
52. Report of the International Study of Kidney Disease in Children. Alternate day steroid therapy in membranoproliferative glomerulonephritis: a randomised controlled clinical trial (abstract) Kidney Int 1982; 21: 150.
53. Schena FP, Gesualdo L, Grandaliano G, Montinaro V. Progression of renal dmage in human glomerulonephritides: is there slight of hand in winning the gene? Kidney Int 1997; 52: 1439-57.